Skip to content

Imiquimod story highlights the issues associated with unpublished trials

A recent commentary in JAMA Dermatology highlights the problems associated with unpublished trials.

It looks at the case of imiquimod, widely considered beneficial for treating children with molluscum contagiosum (a viral infection that affects the skin). According to the commentary, 2 large randomised clinical trials have shown imiquimod is neither safe nor effective in these cases. However, neither trial has been published.

The author of the article predicts that prescriptions of imiquimod would decrease for molluscum contagiosum in children if the results of these trials were made available.

Aspire Scientific Ltd View All

Ryan co-runs Aspire Scientific, a dynamic, forward-thinking medical writing agency. Ryan has a passion for innovation, science and ethical communication.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: